Phio Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:44R0 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
26 Feb 24	Buy€2,097	Robert Bitterman	Individual	2,500	€0.84
01 Jul 23	Buy€5,240	Robert Bitterman	Individual	2,000	€2.64
14 Jun 23	Buy€5,714	Robert Ferrara	Individual	2,000	€2.86

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.4%.

Top 18 shareholders own 4.14% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0.92%	Renaissance Technologies LLC	13,899	€48.7k	-21.9%	no data
0.86%	The Vanguard Group, Inc.	12,877	€45.1k	-29.2%	no data
0.59%	Geode Capital Management, LLC	8,909	€31.2k	-0.26%	no data
0.42%	Cetera Investment Advisers LLC	6,249	€21.9k	0%	no data
0.19%	Caitlin Kontulis	2,920	€10.2k	179%	no data
0.19%	Robert Bitterman	2,878	€10.1k	40.7%	no data
0.18%	Geert Cauwenbergh	2,736	€9.6k	43.8%	no data
0.17%	Robert Ferrara	2,500	€8.8k	50%	no data
0.13%	UBS Asset Management AG	1,919	€6.7k	0%	no data
0.12%	Two Sigma Investments, LP	1,866	€6.5k	-3.47%	no data
0.11%	Jonathan Freeman	1,697	€5.9k	96.4%	no data
0.11%	Curtis Lockshin	1,697	€5.9k	96.4%	no data
0.11%	Two Sigma Securities, LLC, Asset Management Arm	1,642	€5.8k	-11.7%	no data
0.029%	Tower Research Capital LLC	434	€1.5k	-4.62%	no data
0.0082%	Morgan Stanley, Investment Banking and Brokerage Investments	124	€434.5	-0.8%	no data
0.00047%	Wells Fargo & Company, Private Banking and Investment Banking Arm	7	€24.8	0%	no data
0.00027%	JPMorgan Chase & Co, Brokerage and Securities Investments	4	€14.2	-94.4%	no data
0.00007%	BlackRock, Inc.	1	€3.7	0%	no data